Stockholm - Delayed Quote SEK
Hansa Biopharma AB (publ) (HNSA.ST)
25.94
+0.34
+(1.33%)
At close: May 9 at 5:29:46 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 4 |
| Avg. Estimate | -1.85 | -1.74 | -5.68 | -4.84 |
| Low Estimate | -2.04 | -2.1 | -6.09 | -6.38 |
| High Estimate | -1.52 | -1.56 | -5.15 | -1.17 |
| Year Ago EPS | -3.3 | -1.53 | -12.84 | -5.68 |
Revenue Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 4 |
| Avg. Estimate | 64.08M | 74.39M | 319.33M | 569.24M |
| Low Estimate | 60M | 67.95M | 266.44M | 423.12M |
| High Estimate | 67.95M | 82M | 418M | 697.53M |
| Year Ago Sales | 34.3M | 48.66M | 171.32M | 319.33M |
| Sales Growth (year/est) | 86.84% | 52.87% | 86.40% | 78.26% |
Earnings History
| Currency in SEK | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -2.78 | -2.42 | -1.98 | -2.67 |
| EPS Actual | -3.3 | -1.53 | -4.08 | -0.55 |
| Difference | -0.52 | 0.89 | -2.1 | 2.12 |
| Surprise % | -18.71% | 36.69% | -106.06% | 79.43% |
EPS Trend
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.85 | -1.74 | -5.68 | -4.84 |
| 7 Days Ago | -2.02 | -1.57 | -6.09 | -5.61 |
| 30 Days Ago | -2.44 | -2.15 | -9.58 | -8.75 |
| 60 Days Ago | -2.44 | -2.15 | -9.42 | -8.22 |
| 90 Days Ago | -1.68 | -1.71 | -7.47 | -5.49 |
EPS Revisions
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 2 |
| Up Last 30 Days | -- | -- | 1 | 2 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HNSA.ST | 43.84% | -13.73% | 55.76% | 14.74% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Related Tickers
CANTA.ST Cantargia AB (publ)
1.6300
+5.16%
VICO.ST Vicore Pharma Holding AB (publ)
7.94
+4.20%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2032
-1.26%
ATORX.ST Alligator Bioscience AB (publ)
4.1500
+4.56%
FLUI.ST Fluicell AB (publ)
11.50
-1.71%
ACE.ST Ascelia Pharma AB (publ)
3.8550
+1.58%
FLUO.ST FluoGuide A/S
39.90
+0.76%
DMYD-B.ST Diamyd Medical AB (publ)
9.14
-3.08%
XSPRAY.ST Xspray Pharma AB (publ)
32.10
-8.29%
SANION.ST Saniona AB (publ)
8.00
-2.56%